C12Y 304/21092
Endopeptidase clp
Official title: Endopeptidase Clp (3.4.21.92)
C12Y304/21092 (Endopeptidase clp) appears on 4 US grants and 9 published applications in this corpus.
Search patents in C12Y- Granted patents
- 4
- Published applications
- 9
- Assignees
- 6
- Inventors
- 32
- Latest grant
- 7 Oct 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2012 | 0 | 1 |
| 2013 | 0 | 0 |
| 2014 | 0 | 1 |
| 2015 | 0 | 0 |
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 1 | 0 |
| 2019 | 0 | 0 |
| 2020 | 1 | 0 |
| 2021 | 0 | 2 |
| 2022 | 0 | 0 |
| 2023 | 1 | 0 |
| 2024 | 0 | 2 |
| 2025 | 1 | 1 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Methods and organisms with increased carbon flux efficiencies7 Oct 2025US 12,435,346 B2Genomatica, Inc.
- Defined therapeutic microbiota and methods of use thereof6 Jun 2023US 11,666,611 B2The Brigham and Women S Hospital, Inc.
- Methods and organisms with increased carbon flux efficiencies24 Mar 2020US 10,597,684 B2Genomatica, Inc.
- Treatments for Mycobacterium tuberculosis27 Mar 2018US 9,925,251 B2President and Fellows of Harvard College
- Methods and organisms with increased carbon flux efficiencies16 Apr 2026US 2026/0103733 A1Genomatica, Inc.
- Type i-b crispr-associated transposase systems29 May 2025US 2025/0171811 A1Massachusetts Institute of Technology
- Methods and organisms with increased carbon flux efficiencies18 Apr 2024US 2024/0124904 A1Genomatica, Inc.
- Mutant atp-dependent protease, and method for producing l-amino acid using same4 Jan 2024US 2024/0002827 A1Cj Cheiljedang Corporation
- Methods and organisms with increased carbon flux efficiencies20 May 2021US 2021/0147883 A1Genomatica, Inc.
Most cited
By later US patents